Taiwan needs medical resilience

When discussing Taiwan’s resilience in an increasingly uncertain security environment, policymakers often focus on missiles, energy security, food reserves and semiconductor supply chains. Far less attention is paid to a simpler, but equally important question: Can Taiwan keep hospitals functioning and treat people if supply chains are disrupted?

This question deserves greater attention, because a blockade or prolonged period of “gray zone” pressure would affect far more than trade and transportation. The objective would not simply be to interrupt commercial activity, but to transform economic disruption into social fatigue and political pressure. A society might possess advanced technology, strong military capabilities and substantial economic resources, but still become vulnerable if citizens lose confidence in essential services.

Medical resilience should therefore be viewed not merely as a healthcare issue, but a pillar of civilian resilience.

Disruptions to medical supply chains could affect far more than hospitals. Shortages of essential medicines, dialysis supplies, blood products, antibiotics or temperature-sensitive therapies would affect many Taiwanese. What begins as a logistics challenge could evolve into declining public confidence and growing concern about whether normal life can continue.

A blockade does not necessarily succeed because it defeats a military force. It succeeds when sustained disruption weakens society’s willingness and ability to endure. If people are unable to obtain necessary treatment and healthcare providers face mounting operational challenges, the impact could extend well beyond the healthcare sector. Medical continuity should therefore be considered an important component of national resilience and deterrence by denial: the capacity to deny coercion its intended political effect.

Taiwan has already recognized some of these risks. Recent government initiatives have emphasized essential medicine security, stronger monitoring mechanisms and efforts to expand domestic manufacturing capacity. These are important steps, but preparedness discussions continue to revolve around a familiar question: How many days can Taiwan survive?

While stockpiles are necessary, survival is not the same as resilience.

A reserve can buy time, but it cannot automatically identify shortages across institutions, redistribute supplies, qualify alternative suppliers, restore supply chains nor ensure that products with limited shelf lives or specialized storage requirements remain available.

Resilience depends on whether a system can adapt and recover once disruption begins. The more relevant questions are whether authorities know where critical inventories are located, and whether hospitals can coordinate scarce resources, and regulators and private sector partners could transition rapidly from normal operations to crisis management. Clear authority and allocation protocols would also be essential when normal market mechanisms no longer meet urgent clinical needs. Resilience must therefore be measured not only by what Taiwan can store, but also by how effectively it can adapt, replenish and recover.

This challenge is particularly important for medical products. Many medicines have limited shelf lives, specialized storage requirements or complex global supply networks. Some depend on unique ingredients, devices or manufacturing facilities that cannot be replaced quickly. Attempting to stockpile everything would be costly and inefficient. Resilience requires a more targeted strategy.

Taiwan should focus on three priorities:

First, it should establish greater visibility across national inventories of essential medicines and medical supplies. Policymakers need accurate information about where critical products are, how quickly stocks are being consumed and how they can be allocated during emergencies. Hospitals and other healthcare institutions should also have clear procedures for reporting shortages and requesting assistance.

Second, Taiwan should continue diversifying suppliers and developing distributed reserves for selected essential medicines and healthcare products. Reducing dependence on any single source or storage location would help mitigate supply disruptions and avoid creating new points of failure.

Third, Taiwan should establish prearranged cooperation mechanisms with trusted partners. Medical resilience is ultimately a question of access and storage. Unlike larger continental states, Taiwan cannot assume that domestic reserves alone would sustain a prolonged disruption of maritime and air transportation. Working in advance with like-minded partners on emergency logistics, procurement arrangements, regulatory flexibility and supply-sharing would bolster preparedness before a crisis occurs. Such arrangements should be tested during peacetime rather than improvised under pressure.

Ultimately, the argument for medical resilience is strategic rather than medical. A coercive campaign succeeds when disruption turns into exhaustion and exhaustion becomes political pressure. Medical resilience helps ensure that disruptions do not produce that outcome.

Taiwan’s security cannot be measured solely by its military capabilities or the strength of its technology sector. It also depends on whether society can continue functioning under sustained pressure. In today’s security environment, resilience is about more than missiles and microchips. It is also about ensuring that hospitals remain operational, people continue receiving care and essential medical supplies remain available when normal supply chains come under strain.

Hanson Wu is a Taiwan-based healthcare policy professional with experience in pharmaceutical policy, health security and public affairs. He is a graduate researcher for healthcare policy at National Taiwan University.